+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endoscopic Mucosal Resection Technology - Global Strategic Business Report

  • PDF Icon

    Report

  • 192 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139511
The global market for Endoscopic Mucosal Resection Technology was estimated at US$3.4 Billion in 2023 and is projected to reach US$5.7 Billion by 2030, growing at a CAGR of 7.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Endoscopic Mucosal Resection Technology Market - Key Trends and Drivers Summarized

How Is Endoscopic Mucosal Resection Technology Revolutionizing Gastrointestinal Cancer Treatment?

Endoscopic Mucosal Resection (EMR) technology is revolutionizing gastrointestinal cancer treatment by offering a minimally invasive, highly effective option for removing precancerous lesions and early-stage cancers from the digestive tract. EMR is particularly valuable in treating conditions such as esophageal, gastric, and colorectal cancers, where early detection and removal of abnormal tissues can prevent the progression to more advanced disease stages. This technique involves the use of an endoscope - a flexible tube equipped with a camera and instruments - to resect the mucosal layer of the gastrointestinal tract, removing the abnormal tissue without the need for traditional surgery. EMR not only reduces the risks and recovery times associated with open surgery but also preserves the integrity of the gastrointestinal tract, maintaining normal function and quality of life for patients. As awareness and screening for gastrointestinal cancers increase, EMR is becoming a preferred treatment option, transforming the landscape of cancer care by enabling early, less invasive interventions that can significantly improve patient outcomes.

What Innovations Are Enhancing the Functionality of Endoscopic Mucosal Resection Technology?

Innovations in Endoscopic Mucosal Resection (EMR) technology are enhancing its functionality through advancements in imaging, resection techniques, and adjunctive therapies. One of the most significant developments is the integration of high-definition imaging and advanced endoscopic technologies, such as narrow-band imaging (NBI) and chromoendoscopy, which allow for more precise identification and delineation of abnormal tissues. These imaging techniques enable gastroenterologists to detect even subtle lesions that might otherwise be missed, increasing the effectiveness and safety of the resection. Another key innovation is the development of hybrid EMR techniques that combine traditional resection with additional methods, such as submucosal injection or the use of specialized resection devices, to achieve more complete and controlled removal of larger or more complex lesions. This approach minimizes the risk of incomplete resection and recurrence, enhancing the long-term success of the procedure. Additionally, the combination of EMR with adjunctive therapies, such as radiofrequency ablation (RFA) or cryotherapy, is expanding its applicability to a broader range of lesions and improving outcomes for patients with more challenging cases. These innovations are making EMR more effective, safer, and accessible, solidifying its role as a critical tool in the early treatment of gastrointestinal cancers.

How Does Endoscopic Mucosal Resection Impact Patient Outcomes and Treatment Options?

Endoscopic Mucosal Resection (EMR) has a profound impact on patient outcomes and treatment options by providing a less invasive, yet highly effective alternative to traditional surgery for the removal of early-stage cancers and precancerous lesions in the gastrointestinal tract. For patients, EMR offers the potential for a quicker recovery, less postoperative pain, and a lower risk of complications compared to more invasive surgical procedures. The preservation of the gastrointestinal tract's integrity is another significant benefit, as it allows patients to maintain normal digestive functions without the need for extensive resection or reconstruction. This is particularly important in the treatment of conditions like Barrett's esophagus or early-stage colorectal cancer, where the goal is to remove the abnormal tissue while minimizing the impact on the patient's quality of life. Additionally, EMR expands treatment options for patients who may not be suitable candidates for surgery due to age, comorbidities, or the location of the lesion. By offering a minimally invasive option that can be performed on an outpatient basis, EMR reduces the burden on healthcare resources and provides a viable alternative for a broader range of patients. The ability to effectively treat early-stage cancers with EMR also contributes to better long-term outcomes, as early intervention is key to preventing the progression of cancer and improving survival rates. By providing a treatment option that balances effectiveness with patient comfort and safety, EMR is transforming the management of gastrointestinal cancers and precancerous conditions.

What Trends Are Driving Growth in the Endoscopic Mucosal Resection Technology Market?

Several trends are driving growth in the Endoscopic Mucosal Resection (EMR) technology market, including the increasing emphasis on early cancer detection, advancements in endoscopic technology, and the rising demand for minimally invasive procedures. The growing awareness of the importance of early detection in the successful treatment of gastrointestinal cancers is leading to more widespread use of screening programs such as colonoscopy and upper endoscopy. As more lesions and early-stage cancers are identified, the demand for effective, minimally invasive treatment options like EMR is increasing. Advancements in endoscopic technology, including improvements in imaging, precision instrumentation, and hybrid techniques, are also expanding the capabilities of EMR, making it suitable for a wider range of patients and lesions. The shift towards minimally invasive procedures is another significant driver, as both patients and healthcare providers seek treatments that offer reduced recovery times, fewer complications, and lower overall costs. Additionally, the integration of EMR with other emerging therapies, such as endoscopic submucosal dissection (ESD) and ablative techniques, is broadening its application and appeal. The increasing prevalence of gastrointestinal conditions, coupled with an aging population that is more susceptible to these diseases, is further fueling market growth. These trends underscore the expanding role of EMR technology in modern gastrointestinal oncology, as it continues to provide a critical, less invasive option for the effective treatment of early-stage cancers and precancerous conditions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Lift-and-Cut Technique segment, which is expected to reach US$3.0 Billion by 2030 with a CAGR of a 6.6%. The Suck-and-Cut Technique segment is also set to grow at 8.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $936.4 Million in 2023, and China, forecasted to grow at an impressive 7.0% CAGR to reach $877.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Endoscopic Mucosal Resection Technology Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Endoscopic Mucosal Resection Technology Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Endoscopic Mucosal Resection Technology Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Ambu, Inc., Boston Scientific Corporation, ConMed Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 38 Featured):

  • Ambu, Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, LLC
  • Henke-Sass, Wolf GmbH
  • Micro-Tech (Nanjing) Co., Ltd
  • Olympus Corporation
  • SCHOLLY FIBEROPTIC GmbH

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Endoscopic Mucosal Resection Technology - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Endoscopic Mucosal Resection Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Endoscopic Mucosal Resection Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Lift-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Lift-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Lift-and-Cut Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Suck-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Suck-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Suck-and-Cut Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Stomach Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Duodenal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Duodenal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Duodenal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Colon Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 26: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 27: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 28: World Endoscopic Mucosal Resection Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ambu, Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, LLC
  • Henke-Sass, Wolf GmbH
  • Micro-Tech (Nanjing) Co., Ltd
  • Olympus Corporation
  • SCHOLLY FIBEROPTIC GmbH

Table Information